| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Nov―27 |
Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight |
Claudia Ielo, Francesca Fazio, Serena Rocchi, Ilaria Rizzello, Katia Mancuso, Elena Zamagni, et al. (+2) Michele Cavo, Maria Teresa Petrucci |
| 2 |
[GO] |
2022―Oct―19 |
Management of acute promyelocytic leukemia in the setting of acute COVID-19 infection |
Kevin G Shim, Mallory Crain, Kristan Augustin, Karolyn A Oetjen |
| 3 |
[GO] |
2022―Sep―08 |
Corrigendum to ‘Long follow-up of symptomatic Multiple Myeloma patients after Covid-19 vaccination (BNT162b2): A single-institution retrospective experience’ Leukemia research reports 18C (100,342) |
Mele Giuseppe, Romano Claudia, Miccoli Antonella, Santoro Angelo, Pastore Domenico |
| 4 |
[GO] |
2022―Aug―08 |
Long follow-up of symptomatic Multiple Myeloma patients after Covid-19 vaccination (BNT162b2): a single-Institution retrospective experience |
Mele Giuseppe, Romano Claudia, Miccoli Antonella, Santoro Angelo, Pastore Domenico |
| 5 |
[GO] |
2022―Jun―30 |
Spontaneous remission of Chronic Lymphocytic Leucemia in a Patient with SARS-CoV2 |
Hale Bülbül, Hamza Ekmel Nazlı, Aybüke Olgun, Alper Togay, Dudu Solakoğlu Kahraman |
| 6 |
[GO] |
2021―Jul―14 |
Oral etoposide combined with oral arsenic plus retinoic acid for two cases with newly diagnosed high-risk acute promyelocytic leukemia during COVID19 pandemic |
Sheng-ye Lu, Li Wen-jing, Rui Lou, Rui Ma, Ji-hong Zhu, Hao Jiang |
| 7 |
[GO] |
2021―Mar―18 |
Concurrent chronic lymphocytic leukemia and COVID-19: A comprehensive review of epidemiological, diagnostic, and therapeutic challenges |
Yousef Roosta, Farhad Behzadi, Elham Askari, Mortaza Raeisi, Amin Danandeh Mehr, Masoud Nouri-Vaskeh |
| 8 |
[GO] |
2020―Dec―08 |
COVID-19 in patients with Acute Leukemia: two cases with different outcomes |
Venkat Rajasurya, Kathleen Elliott, James Dugan, Jan S Moreb |
| 9 |
[GO] |
2020―Jun―13 |
COVID-19 and Multiple Myeloma |
Dr. Yogesh S Jethava |
| 10 |
[GO] |
2020―Apr―20 |
Rewriting the rules for care of MDS and AML patients in the time of COVID-19 |
Azra Raza, Amer Assal, Abdullah M. Ali, Joseph G. Jurcic |
